06:48:17 Europe / Stockholm

Share price & Turnover

Share price change and turnover during the day of this press release

Calendar

2024-08-26 Quarterly Report 2024-Q2
2024-05-27 Ex-date Ordinary Dividend OBSRV 0.00 NOK
2024-05-24 Annual General meeting
2024-03-13 Year-end Report 2023
2023-11-22 Extra General Meeting 2023
2023-08-25 Quarterly Report 2023-Q2
2023-05-30 Ex-date Ordinary Dividend OBSRV 0.00 NOK
2023-05-26 Annual General meeting
2023-02-17 Year-end Report 2022
2022-11-03 Quarterly Report 2022-Q3
2022-08-25 Quarterly Report 2022-Q2
2022-06-03 Annual General meeting
2022-06-03 Quarterly Report 2022-Q1
2022-06-03 Ex-date Ordinary Dividend OBSRV 0.00 NOK
2022-03-29 Year-end Report 2021
2022-02-04 Extra General Meeting 2022
2021-11-03 Quarterly Report 2021-Q3
2021-08-20 Quarterly Report 2021-Q2
2021-05-25 Ex-date Ordinary Dividend OBSRV 0.00 NOK
2021-05-21 Annual General meeting
2021-05-12 Quarterly Report 2021-Q1
2021-02-23 Year-end Report 2020
2020-11-03 Quarterly Report 2020-Q3
2020-08-18 Quarterly Report 2020-Q2
2020-07-01 Ex-date Ordinary Dividend OBSRV 0.00 NOK
2020-06-30 Annual General meeting
2020-06-16 Extra General Meeting 2020
2020-05-12 Quarterly Report 2020-Q1
2020-02-25 Year-end Report 2019

Description

CountryNorway
ListOAX Equities
SectorHealth care
IndustryMedical technology
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2023-11-10 14:48:20
Oslo, November 10, 2023 - Observe Medical ("the Company" or "Observe Medical")
has received follow-up orders from several distributors including the Spanish
distributor, BM2 Health, for delivery of UnoMeter Abdo Pressure products, with
most recent follow-up orders having a value of approx. NOK 1,3 million.

The total value of orders for the UnoMeter product range has reached
approximately NOK 14 million and several large deliveries have already taken
place. Observe Medicals geographical expansion continues with new distributors
placing first orders on a continuous basis.

"We are experiencing strong demand for our UnoMeter portfolio and we are excited
to keep delivering top-quality products to our customers. We remain focused on
expanding our presence in the markets and building strong relationships with key
distribution partners" said Observe Medical CCO, Jørgen Mann.

For further information, please contact:

Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.